Total Payments
$17,518
2024 Payments
$2,644
Companies
51
Transactions
1,272
Medicare Patients
7,227
Medicare Billing
$462,312
Payment Breakdown by Category
Food & Beverage$17,507 (99.9%)
Education$10.40 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,507 | 1,270 | 99.9% |
| Education | $10.40 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,988 | 143 | $0 (2024) |
| Lilly USA, LLC | $1,706 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,508 | 102 | $0 (2024) |
| PFIZER INC. | $1,464 | 165 | $0 (2024) |
| ABBVIE INC. | $1,119 | 79 | $0 (2024) |
| GlaxoSmithKline, LLC. | $935.13 | 77 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $888.23 | 66 | $0 (2023) |
| Merck Sharp & Dohme LLC | $860.17 | 83 | $0 (2024) |
| Allergan, Inc. | $847.59 | 88 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $708.62 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,644 | 150 | Novo Nordisk Inc ($480.47) |
| 2023 | $2,590 | 151 | Novo Nordisk Inc ($394.08) |
| 2022 | $2,380 | 154 | Novo Nordisk Inc ($282.14) |
| 2021 | $2,023 | 139 | AbbVie Inc. ($326.73) |
| 2020 | $1,917 | 138 | AstraZeneca Pharmaceuticals LP ($307.43) |
| 2019 | $1,954 | 164 | PFIZER INC. ($257.22) |
| 2018 | $1,896 | 176 | AstraZeneca Pharmaceuticals LP ($327.25) |
| 2017 | $2,114 | 200 | Allergan Inc. ($323.56) |
All Payment Transactions
1,272 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Obesity | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PAIN | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Obesity | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: VACCINE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.60 | General |
| 10/31/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,885 | 3,749 | $276,666 | $120,744 |
| 2022 | 25 | 1,782 | 3,584 | $276,379 | $126,378 |
| 2021 | 22 | 1,753 | 3,449 | $258,205 | $117,239 |
| 2020 | 23 | 1,807 | 3,440 | $218,880 | $97,951 |
Total Patients
7,227
Total Services
14,222
Medicare Billing
$462,312
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 630 | $116,550 | $51,243 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 383 | $49,790 | $22,734 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $17,000 | $10,864 | 63.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 145 | $9,425 | $6,141 | 65.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 146 | $11,826 | $5,438 | 46.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 237 | 365 | $18,250 | $4,753 | 26.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 293 | 504 | $6,048 | $4,234 | 70.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 154 | 305 | $14,030 | $2,862 | 20.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 83 | 83 | $3,486 | $2,601 | 74.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 85 | $3,230 | $2,563 | 79.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 37 | $3,515 | $1,526 | 43.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 12 | 165 | $4,125 | $1,476 | 35.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 20 | $1,560 | $1,016 | 65.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 98 | $4,312 | $943.01 | 21.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 133 | 229 | $4,580 | $871.23 | 19.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 18 | 160 | $3,200 | $664.74 | 20.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 30 | 179 | $3,759 | $411.32 | 10.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 29 | 34 | $680.00 | $145.39 | 21.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 41 | 52 | $624.00 | $114.40 | 18.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 15 | $225.00 | $89.46 | 39.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 16 | 16 | $256.00 | $49.76 | 19.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 11 | 13 | $195.00 | $4.34 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 580 | $107,300 | $47,591 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 366 | $47,580 | $21,979 | 46.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 271 | $17,615 | $12,136 | 68.9% |
About Dr. James Mcglothlin, D.O
Dr. James Mcglothlin, D.O is a Family Medicine healthcare provider based in Marion, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1801181367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Mcglothlin, D.O has received a total of $17,518 in payments from pharmaceutical and medical device companies, with $2,644 received in 2024. These payments were reported across 1,272 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($17,507).
As a Medicare-enrolled provider, Mcglothlin has provided services to 7,227 Medicare beneficiaries, totaling 14,222 services with total Medicare billing of $462,312. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Marion, VA
- Active Since 06/13/2011
- Last Updated 01/31/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801181367
Products in Payments
- VRAYLAR (Drug) $860.71
- Ozempic (Drug) $691.53
- TRULICITY (Drug) $652.58
- JARDIANCE (Drug) $608.48
- SYMBICORT (Drug) $547.12
- TRELEGY ELLIPTA (Drug) $542.16
- MOUNJARO (Drug) $515.72
- FARXIGA (Drug) $497.05
- TRINTELLIX (Drug) $492.13
- Wegovy (Drug) $490.85
- XARELTO (Drug) $487.36
- REXULTI (Drug) $486.45
- Trintellix (Drug) $446.49
- UBRELVY (Drug) $433.11
- Kerendia (Drug) $411.33
- CHANTIX (Drug) $386.07
- NURTEC ODT (Drug) $366.83
- BELSOMRA (Drug) $315.05
- Saxenda (Drug) $290.86
- JANUVIA (Drug) $288.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marion
Nicole Kennedy, Md, MD
Family Medicine — Payments: $18,979
Family Medicine $18,979
Chelsea Hamman, Md, MD
Family Medicine — Payments: $18,311
Family Medicine $18,311
Emily Bralley, D.o, D.O
Family Medicine — Payments: $18,013
Family Medicine $18,013
Jennifer Jennings, Md, MD
Family Medicine — Payments: $16,264
Family Medicine $16,264
Eric Graham, Md, MD
Family Medicine — Payments: $16,188
Family Medicine $16,188
Dr. Jodi Fox, M.d, M.D
Family Medicine — Payments: $11,980
Family Medicine $11,980